Last edition
News about Market
NewAmsterdam Pharma and Menarini have received a positive CHMP opinion for Ubeslo and Evlarco, bringing the oral obicetrapib-based therapies one step closer to EU approval for patients with hypercholesterolaemia and mixed dyslipidaemia.
Market | 27/07/2026 | By News Bureau
argenx to Acquire Forte Biosciences
argenx will acquire Forte Biosciences to add the first-in-class anti-CD122 antibody FB102, expanding its immunology pipeline.
Market | 27/07/2026 | By News Bureau | 113
EMA Backs Marketing Authorisation for Janssen's Icotyde in Plaque Psoriasis
CHMP backs marketing authorisation for icotrokinra to treat moderate-to-severe plaque psoriasis in adults and eligible adolescents, potentially making it the first oral IL-23-targeting therapy approved in the EU.
Market | 27/07/2026 | By News Bureau
Bluesight and Pfizer Partner to Expand RFID-Tagged Medications for Hospitals
Bluesight and Pfizer are bringing source-tagged Radio Frequency Identification (RFID) SmartDose medications to hospital pharmacies, streamlining inventory management and reducing manual tagging.
Market | 24/07/2026 | By News Bureau
Sun Pharma Acknowledges Organon Shareholder Approval for Acquisition
Sun Pharma has acknowledged Organon shareholders' approval of the proposed acquisition, marking a key milestone toward completion of the transaction.
Market | 24/07/2026 | By News Bureau | 180
Johnson & Johnson's Ottava Robotic Surgical System Receives US FDA De Novo Authorization
Johnson & Johnson receives US FDA De Novo authorization for the Ottava Robotic Surgical System, the world's first table-integrated soft tissue robotic platform, expanding access to robotic-assisted surgery across multiple general surgery procedures.
Market | 24/07/2026 | By News Bureau
India’s pharma and healthcare sector recorded 65 deals worth USD 13.9 billion in Q2 2026, with record M&A values driven by strategic acquisitions and continued investor focus on specialty pharma, AI-enabled healthcare and innovation-led businesses.
Market | 24/07/2026 | By News Bureau | 150
Trump's Proposed Tariffs on Generic Drug Imports Raise Concerns for India's Pharmaceutical Industry
The US plans to impose a 100 percent tariff on imported generic medicines from August 2028, increasing to 200 percent a year later, prompting Indian drugmakers to reassess export strategies and manufacturing plans.
Market | 23/07/2026 | By News Bureau
Samsung Biologics to Acquire PolyPeptide in All-Cash Deal
Samsung Biologics has launched a CHF 1.46 billion all-cash offer to acquire PolyPeptide, expanding its global CDMO network and multi-modality strategy.
Market | 23/07/2026 | By News Bureau | 114
Ipsen Completes Acquisition of Memo Therapeutics AG
Ipsen has completed its acquisition of Memo Therapeutics AG, adding a first-in-class asset to strengthen its rare disease pipeline.
Market | 23/07/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy